SRR owes plenty of shareholders much more than just 'a few cents,' so we'll certainly be expecting more than our two cents worth. Our long term support deserves to be rewarded, beyond a short term hit and run.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025